Market Overview:
The global swine diagnostic testing market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for pork and rising awareness about animal health and diseases. The market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into immunoassays (ELISA) kits, PCR kits, and others. Immunoassays (ELISA) kit held a dominant share in 2017 owing to its high accuracy and reliability in detecting various diseases in pigs. On the basis of application, veterinary hospitals accounted for a major share in 2017 as it offers comprehensive services such as diagnosis, treatment, surgery etc., for sick animals under one roof. Some key players operating in this market are IDEXX Laboratories Inc., Zoetis Inc., Abaxis Inc., Becton Dickinson & Co.
Product Definition:
Swine diagnostic testing is the process of diagnosing and treating diseases in pigs. The importance of swine diagnostic testing is that it helps to ensure the health and welfare of pigs, while also preventing the spread of disease.
Immunoassays (ELISA) Kits:
Immunoassays (ELISA) kits, it's usage and growth factor in swine diagnostic testing market? By Product (Reagents & Consumables, Instruments), By Application (Diagnostic Test), And Segment Forecasts To 2024 -> The global immunoassay kits, it's usage and growth factor in the swine diagnostic testing market was valued at USD 1.51 billion in 2015.
PCR Kits:
Polymerase Chain Reaction (PCR) is a technique that uses DNA as a probe to identify and amplify specific genetic sequences. The technology was developed in the early 1990s by the Japanese physician/biotechnologist, Dr. Kaynakai Hata, for human identification of cadavers.
Application Insights:
Based on the application, the global market is segmented into veterinary hospitals and clinics. The veterinary hospital segment dominated the market in 2017 owing to increased awareness about swine diseases among farmers and an increase in spending on diagnostics for their animals. This was further augmented by a rise in demand for highly skilled veterinarians due to an increase in animal healthcare concerns among pet owners.
The Veterinary Clinic segment is expected to witness lucrative growth over the forecast period owing to factors such as rising number of piggeries, increasing R&D investments by manufacturers, presence of diagnostic laboratories at these sites that offer advanced testing options along with technological advancements that enhance overall efficiency and effectiveness of diagnostic tests performed thereon pigs & boars. These factors are likely to drive demand from clinics over the forecast period thereby contributing towards overall revenue generation within this region during this time frame.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to increasing incidence of swine diseases and rising demand for diagnostic testing services. In addition, presence of a large number of players coupled with high investment by companies in R&D activities will help North America retain its dominance throughout the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the coming years owing to factors such as growing economy, improving healthcare infrastructure and rising awareness about pig health among farmers. Moreover, government initiatives encouraging vaccination programs are likely to contribute towards regional growth rate during the same period.
Growth Factors:
- Increasing demand for pork and pork products due to rising population and changing dietary preferences
- Growing awareness about the benefits of diagnostic testing for swine health
- Technological advancements in the field of swine diagnostics that improve accuracy and speed of diagnosis
- Rising incidence of diseases in pigs that necessitates use of diagnostic tests for timely detection and treatment
- Increased funding for research on swine diseases, which is driving innovation in the field of diagnostics
Scope Of The Report
Report Attributes
Report Details
Report Title
Swine Diagnostic Testing Market Research Report
By Type
Immunoassays (ELISA) Kits, PCR Kits, Others
By Application
Veterinary Hospitals, Veterinary Clinics
By Companies
Elanco, Merck Sharp & Dohme, Qiagen
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Swine Diagnostic Testing Market Report Segments:
The global Swine Diagnostic Testing market is segmented on the basis of:
Types
Immunoassays (ELISA) Kits, PCR Kits, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Veterinary Hospitals, Veterinary Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Elanco
- Merck Sharp & Dohme
- Qiagen
Highlights of The Swine Diagnostic Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Immunoassays (ELISA) Kits
- PCR Kits
- Others
- By Application:
- Veterinary Hospitals
- Veterinary Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Swine Diagnostic Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Swine diagnostic testing is a process used to identify the presence of diseases in pigs. This can be done through a variety of methods, including blood tests, fecal exams, and tissue samples.
Some of the key players operating in the swine diagnostic testing market are Elanco, Merck Sharp & Dohme, Qiagen.
The swine diagnostic testing market is expected to register a CAGR of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Swine Diagnostic Testing Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Swine Diagnostic Testing Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Swine Diagnostic Testing Market - Supply Chain
4.5. Global Swine Diagnostic Testing Market Forecast
4.5.1. Swine Diagnostic Testing Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Swine Diagnostic Testing Market Size (000 Units) and Y-o-Y Growth
4.5.3. Swine Diagnostic Testing Market Absolute $ Opportunity
5. Global Swine Diagnostic Testing Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Swine Diagnostic Testing Market Size and Volume Forecast by Type
5.3.1. Immunoassays (ELISA) Kits
5.3.2. PCR Kits
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Swine Diagnostic Testing Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Swine Diagnostic Testing Market Size and Volume Forecast by Application
6.3.1. Veterinary Hospitals
6.3.2. Veterinary Clinics
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Swine Diagnostic Testing Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Swine Diagnostic Testing Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Swine Diagnostic Testing Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Swine Diagnostic Testing Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Swine Diagnostic Testing Demand Share Forecast, 2019-2026
9. North America Swine Diagnostic Testing Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Swine Diagnostic Testing Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Swine Diagnostic Testing Market Size and Volume Forecast by Application
9.4.1. Veterinary Hospitals
9.4.2. Veterinary Clinics
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Swine Diagnostic Testing Market Size and Volume Forecast by Type
9.7.1. Immunoassays (ELISA) Kits
9.7.2. PCR Kits
9.7.3. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Swine Diagnostic Testing Demand Share Forecast, 2019-2026
10. Latin America Swine Diagnostic Testing Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Swine Diagnostic Testing Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Swine Diagnostic Testing Market Size and Volume Forecast by Application
10.4.1. Veterinary Hospitals
10.4.2. Veterinary Clinics
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Swine Diagnostic Testing Market Size and Volume Forecast by Type
10.7.1. Immunoassays (ELISA) Kits
10.7.2. PCR Kits
10.7.3. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Swine Diagnostic Testing Demand Share Forecast, 2019-2026
11. Europe Swine Diagnostic Testing Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Swine Diagnostic Testing Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Swine Diagnostic Testing Market Size and Volume Forecast by Application
11.4.1. Veterinary Hospitals
11.4.2. Veterinary Clinics
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Swine Diagnostic Testing Market Size and Volume Forecast by Type
11.7.1. Immunoassays (ELISA) Kits
11.7.2. PCR Kits
11.7.3. Others
11.8. Basis Point Share (BPS) Analysisby Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Swine Diagnostic Testing Demand Share, 2019-2026
12. Asia Pacific Swine Diagnostic Testing Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Swine Diagnostic Testing Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Swine Diagnostic Testing Market Size and Volume Forecast by Application
12.4.1. Veterinary Hospitals
12.4.2. Veterinary Clinics
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Swine Diagnostic Testing Market Size and Volume Forecast by Type
12.7.1. Immunoassays (ELISA) Kits
12.7.2. PCR Kits
12.7.3. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Swine Diagnostic Testing Demand Share, 2019-2026
13. Middle East & Africa Swine Diagnostic Testing Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Swine Diagnostic Testing Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Swine Diagnostic Testing Market Size and Volume Forecast by Application
13.4.1. Veterinary Hospitals
13.4.2. Veterinary Clinics
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Swine Diagnostic Testing Market Size and Volume Forecast by Type
13.7.1. Immunoassays (ELISA) Kits
13.7.2. PCR Kits
13.7.3. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Swine Diagnostic Testing Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Swine Diagnostic Testing Market: Market Share Analysis
14.2. Swine Diagnostic Testing Distributors and Customers
14.3. Swine Diagnostic Testing Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Elanco
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Merck Sharp & Dohme
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Qiagen
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. COMPANY4
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
